US20210154204A1

Inhibitors of receptor interacting protein kinase i for the treatment of …

University of Texas System

Abstract

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Richard T. Lewis
Priority date: November 26, 2019
Filing date: November 19, 2020
Publication date: May 27, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/28/2d/3f/8648d700894c26/US20210154204A1.pdf
Metadata fetched: August 29, 2026 00:28